C-MER Eye Care CEO Boosts Shareholding

C-MER Eye Care Holdings Limited (HK:3309) has released an update.

Dr. Dennis Lam, the Chairman and CEO of C-MER Eye Care Holdings Limited, has increased his shareholding in the company by purchasing 348,000 shares on the market, resulting in a slight increase from approximately 54.98% to 55.00% of the issued share capital. This transaction, executed on July 22, 2024, for a total consideration of HK$920,260, maintains the company’s compliance with Hong Kong’s public float requirements. Shareholders and potential investors are reminded to be mindful of investment risks and to exercise caution in dealing with the company’s securities.

For further insights into HK:3309 stock, check out TipRanks’ Stock Analysis page.